DEFA14A: Allarity Therapeutics Postpones 2024 Annual Stockholders Meeting

Allarity Therapeutics has postponed its 2024 annual meeting of stockholders, originally scheduled for July 26, 2024, to a later date to be determined by the Board.

Summary

• Allarity Therapeutics has postponed its annual meeting of stockholders, which was originally scheduled for July 26, 2024.
• The Board of Directors made the decision on July 25, 2024, acting under the authority granted by the company's bylaws.
• The new date for the Annual Meeting will be determined by the Board at a later time.
• A notice of the postponed Annual Meeting and, if necessary, an updated Proxy Statement will be delivered to stockholders entitled to vote.
• The record date for determining eligible voters remains June 14, 2024, unless a new record date is established for the postponed meeting.
• This supplement should be read in conjunction with the original Proxy Statement filed on July 1, 2024.

Sentiment

Score: 5

Explanation: The document is a neutral announcement of a postponed meeting, with no inherent positive or negative sentiment.

Future Outlook

The Board will determine the date of the postponed Annual Meeting and, if necessary or appropriate, the new record date for the Annual Meeting, and will deliver a notice of the postponed Annual Meeting and, if applicable, an updated Proxy Statement to all stockholders entitled to vote at the postponed Annual Meeting based on the Record Date or a newly established record date for the postponed Annual Meeting, as applicable.

Industry Context

The postponement of a shareholder meeting is not uncommon and can occur for various reasons, such as needing more time to finalize important information or to ensure adequate shareholder participation.

Stakeholder Impact

• Shareholders will need to wait for the rescheduled Annual Meeting to exercise their voting rights.
• Shareholders should monitor for updates regarding the new meeting date and any changes to the Proxy Statement.

Next Steps

• The Board will determine the new date for the Annual Meeting.
• The Board will determine if a new record date is necessary.
• A notice of the postponed Annual Meeting and, if applicable, an updated Proxy Statement will be delivered to stockholders.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Postponement, Stockholders, Allarity Therapeutics